Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 4Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Hemangiosarcoma 2Fallopian Tube Neoplasms 2Uterine Neoplasms 1Thymoma 1Small Cell Lung Carcinoma 1Seminoma 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma 1Recurrent Uterine Sarcoma 1Recurrence 1Primary Myelofibrosis 1Pleural Neoplasms 1Osteosarcoma 1Neoplasms 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Mastocytosis 1Leukemia, Mast-Cell 1

Interventions

Doxorubicin 4Ifosfamide 3Radiotherapy 2Ipilimumab 2Filgrastim 2saracatinib 1perifosine 1pembrolizumab 1fludarabine 1brostallicin 1belinostat 1aldesleukin 1Trabectedin 1Temozolomide 1Sunitinib 1Ritonavir 1Nivolumab 1Mass Spectrometry 1Injections 1Indinavir 1Imatinib Mesylate 1Fluorouracil 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Imatinib Mesylate × Gynecologic × Clear all
NCT00006357 2012-09-24

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
91 enrolled
GastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡